Sort
48,018 grants matching “immunotherapy”
Harnessing adaptive NK cell transfer to deplete viral reservoirs
$760,984David T Evans · University Of Wisconsin-Madison · R01 · FY2025 · AI
Modulation of B Cell Responses in Autoimmunity
$760,953Duke University · U19 · FY2005 · AI
Combination host-directed and antibacterial therapy for pulmonary intracellular infections
$760,910Patrick S. Stayton · University Of Washington · R01 · FY2025 · AI
Project 1 Immunometabolic Determinants of Susceptibility
$760,647Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · AI
Bronx-Lebanon Hospital Center Pediatric ACTU
$760,635Bronx-Lebanon Hosp Ctr (Bronx, Ny) · U01 · FY2004 · AI
Vaccines, Immunoprophylaxis, and Immunotherapy for Coronaviruses
$760,593Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Chemotherapy-free cure of hemoglobin disorders through base editing
$760,457Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2024 · HL
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$760,163Sandra Aung · Ubivac, Llc · R44 · FY2009 · CA
Natural killer cell engineering to target the HIV reservoir
$760,119Jerome A. Zack · University Of California Los Angeles · R01 · FY2023 · AI
Epigenome-wide association study of childhood asthma
$760,089Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2018 · AI
Engineered Immune Cells for T1D
$760,043Everett Meyer · Stanford University · R01 · FY2025 · DK
Reversing HIV T cell dysfunction by aptamer targeting of therapeutic siRNAs
$759,825Eli Gilboa · University Of Miami School Of Medicine · DP1 · FY2016 · DA
Spontaneous and Induced B cell and T cell responses in Alzheimer's Disease
$759,744Marco Colonna · Washington University · R01 · FY2025 · AG
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$759,496Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2020 · CA
Investigational Cancer Therapeutics Training Program
$759,367Alexander Drilon · Sloan-Kettering Inst Can Research · T32 · FY2023 · CA
Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors
$759,285James F Kronauge · Cytosite Biopharma, Inc. · R44 · FY2019 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$759,203Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2025 · CA
The impact of sex and cell death on checkpoint inhibitor hepatotoxicity
$759,135Lily Dara · University Of Southern California · R01 · FY2025 · DK
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$758,985Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$758,985Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
$758,779Obi L. Griffith · Washington University · U24 · FY2019 · CA
Glycolysis and rodent models of Alzheimer's disease
$758,745Qiang Zhang · University Of Iowa · R01 · FY2025 · AG
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$758,639Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
The role of the intestinal microbiome in cancer immunotherapy
$758,368Marcel R M Van Den Brink · Beckman Research Institute/City Of Hope · R35 · FY2023 · CA
Integrated Multi-omics of Melioidosis
$758,287Timothy Eoin West · University Of Washington · R01 · FY2021 · AI